Hello readers,

As funding freezes grip global aid, USAID’s $60 billion halt threatens to shut down essential programs, leaving health initiatives scrambling for survival. Meanwhile, the FDA's approach to antibiotic approvals raises serious concerns, prioritizing lab results over patient outcomes. In Europe, STIs are surging, with drug-resistant gonorrhea adding to the crisis. South African activists sound the alarm on HIV funding, while a proposed EU ban on ‘forever chemicals’ could jeopardize hundreds of essential medicines. And as debates over weight-loss drugs for kids intensify, gender disparities in science and healthcare remain a pressing issue. In geopolitics, Trump’s demands for Ukraine’s rare earth minerals add another layer of tension. Stay informed as we break down these crucial developments shaping global health and policy.

A massive funding freeze threatens critical aid programs. The USAID halt endangers over $60 billion, forcing layoffs, potential shutdowns, and crippling organizations that depend on it for up to 90% of their income. DEVEX

The FDA is getting antibiotics all wrong. Instead of focusing on patient survival, it prioritizes new drugs based on lab results, often approving ineffective antibiotics with serious side effects while neglecting better treatment strategies like immune-boosting therapies. STAT

STIs are on the rise across Europe, with gonorrhea cases soaring by 31% in 2023. Syphilis infections also increased by 13%, drug-resistant gonorrhea remains a concern, and the ECDC emphasizes prevention through condom use, open communication, and responsible antibiotic use. CIDRAP

South African activists demand urgent action to prevent an HIV funding crisis. They urge President Ramaphosa to intervene after Trump’s executive order halted USAID support, threatening essential treatments and services despite some PEPFAR waivers. HEALTH POLICY WATCH

A ban on ‘forever chemicals’ could put over 600 essential medicines at risk in Europe. The proposed EU restrictions on PFAS may disrupt pharmaceutical production, with industry leaders warning of halted manufacturing due to a lack of alternatives, while the EU Commission assesses the potential impact. EUROBSEVER

Should kids take weight-loss drugs, or is it too risky? Chloe, a 15-year-old with PCOS, struggled with obesity despite diet and exercise, but after nine months on semaglutide, she lost 25 pounds and feels it’s worth the side effects. Many parents, desperate for solutions, are turning to platforms like Mochi Health, raising ethical and medical debates about prescribing weight-loss drugs to children. FINANCIAL TIMES

Where are the women in science and healthcare? Despite their significant contributions, women face systemic barriers in research, leadership, and innovation, leading to gender disparities in health outcomes and scientific progress. Ensuring gender equity in healthcare and STEM is not just about fairness—it’s a crucial step toward more effective, inclusive solutions for everyone. EPHA

Trump demands $500B in rare earth minerals from Ukraine for continued U.S. support. In a Fox News interview, he stated that Ukraine has "essentially agreed" to provide these resources as compensation for America's financial aid, emphasizing that the U.S. must get something in return. POLITICO